Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF): Price and Financial Metrics
Can-Fite Biopharma Ltd Sponsored ADR (Israel) (CANF)
Today's Latest Price: $1.89 USD
0.06 (3.28%)
Updated Dec 4 8:00pm
Add CANF to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 369 in Miscellaneous
See all "A" rated Strong Buy stocks
CANF Stock Summary
- The ratio of debt to operating expenses for Can-Fite BioPharma Ltd is higher than it is for about just 4.36% of US stocks.
- With a price/sales ratio of 332.44, Can-Fite BioPharma Ltd has a higher such ratio than 98.58% of stocks in our set.
- Revenue growth over the past 12 months for Can-Fite BioPharma Ltd comes in at 1,140.3%, a number that bests 99.31% of the US stocks we're tracking.
- Stocks that are quantitatively similar to CANF, based on their financial statements, market capitalization, and price volatility, are ONTX, CLDX, ARCT, ADAP, and FIXX.
- CANF's SEC filings can be seen here. And to visit Can-Fite BioPharma Ltd's official web site, go to www.canfite.com.
CANF Stock Price Chart Interactive Chart >
CANF Price/Volume Stats
| Current price | $1.89 | 52-week high | $4.44 |
| Prev. close | $1.83 | 52-week low | $1.08 |
| Day low | $1.83 | Volume | 961,313 |
| Day high | $1.94 | Avg. volume | 973,285 |
| 50-day MA | $1.81 | Dividend yield | N/A |
| 200-day MA | $1.85 | Market Cap | 29.13M |
Loading social stream, please wait...